International Society for Stem Cell Research

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
International Society for Stem Cell Research
FoundedMarch 30, 2001; 17 years ago (2001-03-30)[1]
Legal status501(c)(3) nonprofit organization[2]
HeadquartersSkokie, Illinois, United States
Hans C. Clevers[3]
Nancy Witty[4]
Revenue (2014)
Expenses (2014)$4,186,224[2]
Employees (2014)
Volunteers (2014)

The International Society for Stem Cell Research (ISSCR) is an independent 501(c)(3) nonprofit organization based in Skokie, Illinois, United States.[2] The organization's mission is to promote and foster the exchange and dissemination of information and ideas relating to stem cells, to encourage the general field of research involving stem cells, and to promote professional and public education in all areas of stem cell research and application.[2]


The International Society for Stem Cell Research was officially incorporated on March 30, 2001,[1] to foster the exchange of information on stem cell research.[5] Leonard Zon, professor of pediatrics at Harvard Medical School, served as the organization's first president.[6]

In June 2003, the International Society for Stem Cell Research held its first convention.[7] More than 600 scientists attended, many of whom expressed frustration over restrictions that President George W. Bush's administration had placed on the field of stem-cell research, slowing the pace of research.[7] Scientists who were leaders in their fields are prohibited from using funding from the National Institutes of Health to conduct certain experiments that could provide significant medical achievements.[8]

In 2013, the Society's official journal, Stem Cell Reports, was established; it is published monthly by Cell Press on the Society's behalf.[9]

In March 2015, scientists, including an inventor of CRISPR, urged a worldwide moratorium on germline gene therapy, writing "scientists should avoid even attempting, in lax jurisdictions, germline genome modification for clinical application in humans" until the full implications "are discussed among scientific and governmental organizations".[10][11][12][13]

After the publication that a Chinese group had used CRISPR to modify a gene in human embryos, the group repeated their call for a moratorium on "attempts at human clinical germ-line genome editing while extensive scientific analysis of the potential risks is conducted, along with broad public discussion of the societal and ethical implications."[14]


  1. ^ a b "International Society for Stem Cell Research, Inc." Corporations Division. Secretary of the Commonwealth of Massachusetts. Accessed on May 17, 2016.
  2. ^ a b c d e f g h i "Form 990: Return of Organization Exempt from Income Tax". International Society for Stem Cell Research. Guidestar. December 31, 2014.
  3. ^ "Officers and Board of Directors". International Society for Stem Cell Research. Accessed on February 12, 2018.
  4. ^ "Headquarters Staff". International Society for Stem Cell Research. Accessed on May 17, 2016.
  5. ^ "About Us". International Society for Stem Cell Research.
  6. ^ Parello, Nancy. "Frozen Embryos' Heated Debate: Couples, Doctors Face Ethical Issues". The Record (New Jersey). August 20, 2001. p. A1.
  7. ^ a b "Analysis: Slow Progress Of Stem Cell Research". Morning Edition. National Public Radio. June 12, 2003.
  8. ^ Gorner, Peter; Kotulak, Ronald. "Cloned human embryos mature, yield stem cells: Koreans' controversial breakthrough gives hope for medical treatments". Chicago Tribune via The Houston Chronicle. February 12, 2004.
  9. ^ Mummery, Christine; Fischer, Yvonne; Gathier, Atie (2013-06-04). "Welcome to Stem Cell Reports". Stem Cell Reports. 1 (1): 1–2. doi:10.1016/j.stemcr.2013.05.003. ISSN 2213-6711. PMC 3757740. PMID 24052935.
  10. ^ Wade, Nicholas (19 March 2015). "Scientists Seek Ban on Method of Editing the Human Genome". New York Times. Retrieved 20 March 2015.
  11. ^ Pollack, Andrew (3 March 2015). "A Powerful New Way to Edit DNA". New York Times. Retrieved 20 March 2015.
  12. ^ Baltimore, David; Berg, Paul; Botchan, Dana; Charo, R. Alta; Church, George; Corn, Jacob E.; Daley, George Q.; Doudna, Jennifer A.; Fenner, Marsha; Greely, Henry T.; Jinek, Martin; Martin, G. Steven; Penhoet, Edward; Puck, Jennifer; Sternberg, Samuel H.; Weissman, Jonathan S.; Yamamoto, Keith R. (19 March 2015). "A prudent path forward for genomic engineering and germline gene modification". Science. 348: 36–8. doi:10.1126/science.aab1028. PMC 4394183. PMID 25791083. Retrieved 20 March 2015.
  13. ^ Lanphier, Edward; Urnov, Fyodor; Haecker, Sarah Ehlen; Werner, Michael; Smolenski, Joanna (26 March 2015). "Don't edit the human germ line". Nature. 519: 410–411. doi:10.1038/519410a. PMID 25810189. Retrieved 20 March 2015.
  14. ^ "Chinese Manipulation of Human Embryo Genes Draws Rebuke". Wall Street Journal. 23 April 2015.

External links[edit]